Ecolab has agreed to acquire AkzoNobel's Purate business, which specializes in global antimicrobial water treatment technology, the companies announced on Wednesday.
With 2012 revenue of approximately $23 million, the Purate business provides patented, proprietary chlorine dioxide programs for use in a wide array of water treatment applications.
Completion of the deal is subject to customary regulatory clearances and other standard closing conditions.
"Chlorine dioxide is recognized as an excellent antimicrobial agent to control biologic growth primarily in cooling towers and a wide variety of other industrial water treatment applications," said Timothy Mulhere, Ecolab executive vice president and president of its global water and process services segment.
"Purate's patented technologies complement our offerings globally, including our 3D TRASAR technology programs, which help address our customers' needs for clean water within industrial manufacturing and lower total cost of operations," he added.
The 3D TRASAR technology combines chemistry, remote services and sophisticated monitoring and controls to improve a range of industrial operations to help customers reduce water use, improve energy efficiency and lower total cost of operations, according to Ecolab officials.
The 3D TRASAR cooling water technology has been recognized with a United States Presidential Green Chemistry Award.